Traverso Chambers Private Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
$398K Sell
683
-22
-3% -$12.8K 0.1% 85
2023
Q3
$379K Buy
705
+26
+4% +$13.4K 0.1% 80
2023
Q2
$318K Hold
679
0.08% 90
2023
Q1
$233K Hold
679
0.06% 105
2022
Q4
$248K Hold
679
0.07% 97
2022
Q3
$220K Hold
679
0.07% 106
2022
Q2
$220K Buy
+679
New +$204K 0.07% 102

Other funds holding LLY

Traverso Chambers Private Wealth Management's LLY Position: Q4 2023 in Review

Traverso Chambers Private Wealth Management reduced its Eli Lilly (LLY) stake by 3.1% in Q4 2023, selling an estimated $12.8K and leaving 683 shares worth $398K. The position accounts for 0.1% of the portfolio, ranked #85.

Traverso Chambers Private Wealth Management first reported a position in LLY in Q2 2022 and has held it in 7 quarters since. 3,272 funds tracked by Wall St. Rank hold LLY as of Q4 2023.

  • Traverso Chambers Private Wealth Management held 683 shares of Eli Lilly worth $398K as of Q4 2023.
  • Traverso Chambers Private Wealth Management sold 22 Eli Lilly shares in Q4 2023, an estimated $12.8K.
  • Eli Lilly made up 0.1% of Traverso Chambers Private Wealth Management's portfolio in Q4 2023, its #85 holding.
  • Traverso Chambers Private Wealth Management first reported a position in Eli Lilly in Q2 2022 and has held it in 7 quarters since.
  • 3,272 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2023.

Based on Traverso Chambers Private Wealth Management's 13F filing for Q4 2023, filed 9 Jan 2024.